BioSpace News Archive

Independent testing laboratory to launch in Southern California

GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced positive top-line results of a randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX

Conference Call with Live Audio Webcast on Tuesday May 14th at 9:00 AM ET

Gaye prepares to take on new role as global recruitment for a new CEO is underway

The Paralysis Resource Center provides information, resources and grants to support the 5.4 million Americans living with paralysis [08-May-2019] SHORT HILLS, N.J. , May 8, 2019 /PRNewswire/ -- The Christopher & Dana Reeve Foundation Paralysis Resource Center (PRC), a free, comprehensive, national service for individuals living with paralysis and their caregivers,

ITM Isotopen Technologien München AG announced the lease of a new building in Neufahrn near Munich to increase the production capacity of no-carrier-added Lutetium-177 and high-purity Lutetium-177 containing radiopharmaceuticals.

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as an R&D pipeline of medications targeting diseases with high unmet medical needs, will report financial results for the three months ended March 31, 2019,

IVERIC bio announced financial and operating results for the first quarter ended March 31, 2019 and provided a business update.

Vitamin Angels is thrilled to be a recipient of its 8th 4-star rating, the highest value score available, from Charity Navigator, the nation’s premier charity evaluator.

Stellar Biotechnologies, Inc. reported financial results for the three and six months ended March 31, 2019 and provided an update on its business.